221 related articles for article (PubMed ID: 30739123)
1. Advanced Hepatocellular Carcinoma with Bone Metastases: Prevalence, Associated Factors, and Survival Estimation.
Guo X; Xu Y; Wang X; Lin F; Wu H; Duan J; Xiong Y; Han X; Baklaushev VP; Xiong S; Chekhonin VP; Peltzer K; Wang G; Zhang C
Med Sci Monit; 2019 Feb; 25():1105-1112. PubMed ID: 30739123
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma.
Hu C; Yang J; Huang Z; Liu C; Lin Y; Tong Y; Fan Z; Chen B; Wang C; Zhao CL
BMC Cancer; 2020 Jun; 20(1):494. PubMed ID: 32487048
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of site-specific extra-hepatic disease in hepatocellular carcinoma: a SEER database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mehrabi A; Schöb O; Giryes A; Abdel-Rahman O
Expert Rev Gastroenterol Hepatol; 2017 Jul; 11(7):695-701. PubMed ID: 28276812
[TBL] [Abstract][Full Text] [Related]
4. Impact of homogeneous and heterogeneous risk factors on the incidence and prognosis of brain metastases in patients with hepatocellular carcinoma.
Lin X; Zhang P; Huang R; Huang Y; Sun J; Zheng H; Tian X; Wang X
Ann Palliat Med; 2020 Sep; 9(5):2654-2667. PubMed ID: 32921091
[TBL] [Abstract][Full Text] [Related]
5. Real-World Study of the Incidence, Risk Factors, and Prognostic Factors Associated with Bone Metastases in Women with Uterine Cervical Cancer Using Surveillance, Epidemiology, and End Results (SEER) Data Analysis.
Zhang Y; Guo X; Wang G; Ma W; Liu R; Han X; Li L; Baklaushev VP; Bryukhovetskiy AS; Wang W; Wang X; Zhang C
Med Sci Monit; 2018 Sep; 24():6387-6397. PubMed ID: 30207328
[TBL] [Abstract][Full Text] [Related]
6. Regional Lymph Node Involvement Is Associated With Poorer Survivorship in Patients With Chondrosarcoma: A SEER Analysis.
Wan L; Tu C; Li S; Li Z
Clin Orthop Relat Res; 2019 Nov; 477(11):2508-2518. PubMed ID: 31283732
[TBL] [Abstract][Full Text] [Related]
7. Patterns of bone metastases in newly diagnosed colorectal cancer: a real-world analysis in the SEER database.
Guo X; Zhang C; Ma W; Tian F; Xu G; Han X; Sun P; Baklaushev VP; Bryukhovetskiy AS; Wang G; Ma Y; Wang X
Int J Colorectal Dis; 2019 Mar; 34(3):533-543. PubMed ID: 30617414
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and risk differences of different tumor sizes on distant metastases of hepatocellular carcinoma: A retrospective cohort study in the SEER database.
Yan B; Bai DS; Zhang C; Qian JJ; Jin SJ; Jiang GQ
Int J Surg; 2020 Aug; 80():94-100. PubMed ID: 32619622
[TBL] [Abstract][Full Text] [Related]
10. Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database.
Ding J; Wen Z
BMC Cancer; 2021 Oct; 21(1):1157. PubMed ID: 34715816
[TBL] [Abstract][Full Text] [Related]
11. Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection?
Fernandez-Sevilla E; Allard MA; Selten J; Golse N; Vibert E; Sa Cunha A; Cherqui D; Castaing D; Adam R
Liver Transpl; 2017 Apr; 23(4):440-447. PubMed ID: 28187493
[TBL] [Abstract][Full Text] [Related]
12. The prognostic analysis of different metastatic patterns in advanced liver cancer patients: A population based analysis.
Chen J
PLoS One; 2018; 13(8):e0200909. PubMed ID: 30102707
[TBL] [Abstract][Full Text] [Related]
13. Effect of marital status on the survival of patients with hepatocellular carcinoma treated with surgical resection: an analysis of 13,408 patients in the surveillance, epidemiology, and end results (SEER) database.
Wu C; Chen P; Qian JJ; Jin SJ; Yao J; Wang XD; Bai DS; Jiang GQ
Oncotarget; 2016 Nov; 7(48):79442-79452. PubMed ID: 27769053
[TBL] [Abstract][Full Text] [Related]
14. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
15. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
16. Cyberknife treatment for advanced or terminal stage hepatocellular carcinoma.
Kato H; Yoshida H; Taniguch H; Nomura R; Sato K; Suzuki I; Nakata R
World J Gastroenterol; 2015 Dec; 21(46):13101-12. PubMed ID: 26673627
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma.
Ni JY; Sun HL; Chen YT; Luo JH; Chen D; Jiang XY; Xu LF
World J Gastroenterol; 2014 Dec; 20(46):17483-90. PubMed ID: 25516662
[TBL] [Abstract][Full Text] [Related]
18. Extrahepatic metastases occur in a minority of hepatocellular carcinoma patients treated with locoregional therapies: analyzing patterns of progression in 285 patients.
Senthilnathan S; Memon K; Lewandowski RJ; Kulik L; Mulcahy MF; Riaz A; Miller FH; Yaghmai V; Nikolaidis P; Wang E; Baker T; Abecassis M; Benson AB; Omary RA; Salem R
Hepatology; 2012 May; 55(5):1432-42. PubMed ID: 22109811
[TBL] [Abstract][Full Text] [Related]
19. Predictors of survival after resection of early hepatocellular carcinoma.
Nathan H; Schulick RD; Choti MA; Pawlik TM
Ann Surg; 2009 May; 249(5):799-805. PubMed ID: 19387322
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Homogeneous and Heterogeneous Factors for Bone Metastasis in Esophageal Cancer.
Zhang J; Ma W; Wu H; Wang J; Lin Y; Wang X; Zhang C
Med Sci Monit; 2019 Dec; 25():9416-9425. PubMed ID: 31821313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]